WASHINGTON, Dec. 22, 2016 /PRNewswire-USNewswire/ -- The Community Oncology Alliance (COA) announced today that Jeffrey Vacirca, MD, FACP, CEO and managing partner/director of clinical research at New York Cancer Specialists in Long Island, New York has been elected president of COA for a one year term beginning on January 1, 2017.
"It is an honor to be elected president of the Community Oncology Alliance. As we saw clearly in 2016, COA plays a critical role in supporting and defending community oncology practices and the patients we serve," said Dr. Vacirca. "I look forward to working with the entire oncology community to advance initiatives that improve our nation's cancer care system, including cancer care payment and delivery reform such as the Oncology Medical Home (OMH) and the Oncology Care Model (OCM); continued examination of the broken 340B Drug Discount Program; ensuring Pharmacy Benefits Managers (PBMs) do not restrict patient access to care and treatment; and more."
In addition to Dr. Vacirca, new Executive Committee officers and members of the Board of Directors were elected. A complete and updated list of Officers and Board members can be viewed here.
"On behalf of the COA Executive Committee, I want to welcome the new and continuing Board members and thank them for their service," said incoming COA Vice President Michael Diaz, MD of Florida Cancer Specialists & Research Institute. "Their leadership ensures that COA will continue to see success in its mission of ensuring that all Americans have access to high quality, affordable cancer care in their communities."
COA is a non-profit, 501.c.6 organization overseen by community oncologists. COA has an elected Executive Committee of Officers that reports to a volunteer Board of Directors who direct its management by an Executive Director and staff.
About Community Oncology Alliance
The Community Oncology Alliance (COA) is a non-profit organization dedicated solely to preserving and protecting access to community cancer care, where the majority of Americans with cancer are treated. COA leads community cancer clinics in navigating an increasingly challenging environment to provide efficiencies, patient advocacy, and proactive solutions to Congress and policymakers. To learn more about COA visit www.CommunityOncology.org.
SOURCE Community Oncology Alliance